Tech Talk-BioPharm
At the Tech Talk, we will delve into current tech trends, challenges, and success strategies in both industry and academic research, employing various formats including fireside chats, panel discussions, demos, and expert speeches.
Chair
Jae Beom Kim
Director
Alliance Management Gilead Sciences
Co-Chair
Sehyun Kim
Director
Business Development & License
Merck
Tech Talk - BioPharm Session
The session will explore global pharmaceutical trends, blockbuster drug development, bio-academic research, and partnerships by assessing the current state of technological advancements, trends, and visions in the biopharmaceutical field.
Tech Talk BioPharm Session I
Current Drug Discovery Trends - August 23 (Friday) 4 PM - 5 PM PST
Martin Rhee, MD
Director, Gilead
Title: Sunlenca Discovery to Clinic
Jung Han, PhD
President / Chief Development Officer
Pharos iBio & Therapeutics
Title: The use of AI for clinical drug development and repurposing
JinHwan Han, PhD
Principal Scientist, Merck
Title: ADC Trend in Drug Discovery (TBA)
Business Development and Strategic Partnership - August 23 (Friday) 5 PM - 6 PM PST
Amy Toro
Covington
Title: General License business Contract (TBA)
Ben Youn, Phd MBA
Investment Associate
Omega Fund
Title: BD from VC perspectives (TBA)
Renee Yao
Ecosystem BD, Nvidia
Title: AO Pulse: LLM in Healthcare Life Science
Tech Talk BioPharm Session II
Fireside Chat-Startup Journey - August 24 (Saturday) 8:30 AM - 9:30 AM PST
Sehyun Kim
Moderator, Merck MSD
Sehyun Kim
Moderator, Merck MSD
Sehyun Kim
Moderator, Merck MSD
Title: Round Table Discussion /Q&A
Academic to Industry Career Transition - August 24 (Saturday) 9:30 AM - 10:30 AM PST
Sehyun Kim
Moderator, Merck MSD
Sehyun Kim
Moderator, Merck MSD
Sehyun Kim
Moderator, Merck MSD